Avinger Surged Over 31% During the Trading Hours but Slipped Over 5% in Extended Trading on Wednesday

Dow Jones2023-09-21

Avinger shares moved 31.96% higher during the trading hours but slipped 5.73% in extended trading on Wednesday, after closing 72% higher on Tuesday.

On Monday, the medical device company's stock jumped after the company made a full commercial launch of its Tigereye ST next generation image-guided chronic total occlusion crossing system.

The stock hit its 52-week low of $4.14 on Friday, and is still down 35% over the past 12 months.

The company said that with the initiation of a full commercial launch, all current and prospective accounts can now order the Tigereye ST device.

"This device represents one of the most significant advancements in Avinger's image-guided technologies for the treatment of peripheral artery disease," said Chief Medical Officer Jaafer Golzar.

Prior to full commercialization, Avinger conducted a limited launch at 11 clinical centers in the U.S., with about 50 chronic total occlusion procedures performed with Tigereye ST by 13 physicians. The initial cases showed a positive safety profile, efficacy in crossing very challenging lesions, and high product reliability, the company said.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

4

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2369113429?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-09-21 10:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2369113429","market":"us","top_or_hot":-1,"title":"Avinger Surged Over 31% During the Trading Hours but Slipped Over 5% in Extended Trading on Wednesday","media":"Dow Jones","content":"<html><head></head><body><p>Avinger shares moved 31.96% higher during the trading hours but slipped 5.73% in extended trading on Wednesday, after closing 72% higher on Tuesday.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f6e998149d7afd3a43a18e120dc346ef\" tg-width=\"194\" tg-height=\"105\"/></p><p>On Monday, the medical device company&#39;s stock jumped after the company made a full commercial launch of its Tigereye ST next generation image-guided chronic total occlusion crossing system.</p><p>The stock hit its 52-week low of $4.14 on Friday, and is still down 35% over the past 12 months.</p><p>The company said that with the initiation of a full commercial launch, all current and prospective accounts can now order the Tigereye ST device.</p><p>&#34;This device represents one of the most significant advancements in Avinger&#39;s image-guided technologies for the treatment of peripheral artery disease,&#34; said Chief Medical Officer Jaafer Golzar.</p><p>Prior to full commercialization, Avinger conducted a limited launch at 11 clinical centers in the U.S., with about 50 chronic total occlusion procedures performed with Tigereye ST by 13 physicians. The initial cases showed a positive safety profile, efficacy in crossing very challenging lesions, and high product reliability, the company said.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Avinger Surged Over 31% During the Trading Hours but Slipped Over 5% in Extended Trading on Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAvinger Surged Over 31% During the Trading Hours but Slipped Over 5% in Extended Trading on Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-09-21 10:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Avinger shares moved 31.96% higher during the trading hours but slipped 5.73% in extended trading on Wednesday, after closing 72% higher on Tuesday.On Monday, the medical device company's stock jumped...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2369113429","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2369113429","pubTimestamp":1695262407,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Avinger shares moved 31.96% higher during the trading hours but slipped 5.73% in extended trading on Wednesday, after closing 72% higher on Tuesday.On Monday, the medical device company's stock jumped after the company made a full commercial launch of its Tigereye ST next generation image-guided chronic total occlusion crossing system.The stock hit its 52-week low of $4.14 on Friday, and is still down 35% over the past 12 months.The company said that with the initiation of a full commercial laun","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"Avinger在交易时段飙升超过31%，但在周三的延长交易中下滑超过5%","themeId":"c5bbfdf5f7964880af97c1d6f417052c","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{},"content_text":"Avinger shares moved 31.96% higher during the trading hours but slipped 5.73% in extended trading on Wednesday, after closing 72% higher on Tuesday.On Monday, the medical device company's stock jumped after the company made a full commercial launch of its Tigereye ST next generation image-guided chronic total occlusion crossing system.The stock hit its 52-week low of $4.14 on Friday, and is still down 35% over the past 12 months.The company said that with the initiation of a full commercial launch, all current and prospective accounts can now order the Tigereye ST device.\"This device represents one of the most significant advancements in Avinger's image-guided technologies for the treatment of peripheral artery disease,\" said Chief Medical Officer Jaafer Golzar.Prior to full commercialization, Avinger conducted a limited launch at 11 clinical centers in the U.S., with about 50 chronic total occlusion procedures performed with Tigereye ST by 13 physicians. The initial cases showed a positive safety profile, efficacy in crossing very challenging lesions, and high product reliability, the company said.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":4,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2369113429"}